newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Announced Thorough Evaluation of a Range of Potential Strategic OpportunitiesContinued GBM Study Start-up ActivitiesEnded Quarter with $25.9 million in Cash, Cash Equivalents and Marketable Securities CHARLOTTESVILLE,